Alexandre Guérémy
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Alexandre Guérémy has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
E. Fortanier
Referral Centre for Neuromuscular Diseases and ALS La Timone Hospital University Marseille France
2 shared publicationsE. Salort‐Campana
Referral Centre for Neuromuscular Diseases and ALS La Timone Hospital University Marseille France
2 shared publications- Shahram Attarian
Reference Center for Neuromuscular Diseases and ALS Timone University Hospital Aix‐Marseille University Marseille France
2 shared publications A. Behin
Hôpital Pitié‐Salpêtrière Centre de Référence Des Maladies Neuromusculaires Paris Est, AP‐HP Paris France
1 shared publicationA. Grapperon
Referral Centre for Neuromuscular Diseases and ALS La Timone Hospital University Marseille France
1 shared publicationA. Nadaj Pakleza
Centre de Référence Des Maladies Neuromusculaires NEIdF, Service de Neurologie Hôpitaux Universitaires de Strasbourg Strasbourg France
1 shared publication
Latest Publications
- Open Access
- 25 June 2026
- Published by Wiley in European Journal of Neurology
- Vol. 33 (6) , e70631
Quantitative Neuromuscular MRI in CIDP Patients: Interest of a Multiparametric Approach
Objective: Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is characterized by heterogeneous clinical presentations and the absence of validated imaging biomarkers. Although several quantitative MRI (qMRI) parameters have been investigated individually, their respective diagnostic and clinical relevance remains unclear. Methods: Twenty‐eight CIDP patients (21 typical, 7 multifocal) were prospectively enrolled and compared with 13 age‐ and sex‐matched healthy controls and 17 patients with symptomatic hereditary transthyretin amyloid neuropathy (vATTR). All participants underwent 1.5 T qMRI of the sciatic and tibial nerves and of the thigh and leg muscles. Nerve and muscle volume, magnetization transfer ratio (MTR), fat fraction (FF), and T2 relaxation time were extracted. Clinical assessment included ONLS, RODS, and MRC sum score, while electrophysiological evaluation included fibular compound motor action potentials and tibialis anterior MUNIX. Imaging parameters were compared between groups and correlated with clinical and neurophysiological measures. Results: CIDP patients showed significant differences compared with controls in both nerve and muscle metrics. Nerve volume was increased and MTR decreased at both sciatic and tibial levels ( p < 0.005). At the muscle level, leg muscles showed increased fat fraction and decreased MTR, while T2 values and muscle volume did not differ significantly. MTR showed the strongest correlations with disability scores and MUNIX. Compared with vATTR patients, CIDP patients had lower sciatic nerve MTR, whereas vATTR patients exhibited larger nerve volumes and more pronounced muscle abnormalities. Conclusions: Nerve volume appears to be a sensitive diagnostic marker, while MTR may reflect disease burden. A multiparametric qMRI approach may improve diagnosis and monitoring in CIDP.
- 25 June 2026
- Published by Wiley in European Journal of Neurology
- Vol. 33 (6) , e70631
Open AccessQuantitative Neuromuscular MRI in CIDP Patients: Interest of a Multiparametric Approach
Objective: Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is characterized by heterogeneous clinical presentations and the absence of validated imaging biomarkers. Although several quantitative MRI (qMRI) parameters have been investigated individually, their respective diagnostic and clinical relevance remains unclear. Methods: Twenty‐eight CIDP patients (21 typical, 7 multifocal) were prospectively enrolled and compared with 13 age‐ and sex‐matched healthy controls and 17 patients with symptomatic hereditary transthyretin amyloid neuropathy (vATTR). All participants underwent 1.5 T qMRI of the sciatic and tibial nerves and of the thigh and leg muscles. Nerve and muscle volume, magnetization transfer ratio (MTR), fat fraction (FF), and T2 relaxation time were extracted. Clinical assessment included ONLS, RODS, and MRC sum score, while electrophysiological evaluation included fibular compound motor action potentials and tibialis anterior MUNIX. Imaging parameters were compared between groups and correlated with clinical and neurophysiological measures. Results: CIDP patients showed significant differences compared with controls in both nerve and muscle metrics. Nerve volume was increased and MTR decreased at both sciatic and tibial levels ( p < 0.005). At the muscle level, leg muscles showed increased fat fraction and decreased MTR, while T2 values and muscle volume did not differ significantly. MTR showed the strongest correlations with disability scores and MUNIX. Compared with vATTR patients, CIDP patients had lower sciatic nerve MTR, whereas vATTR patients exhibited larger nerve volumes and more pronounced muscle abnormalities. Conclusions: Nerve volume appears to be a sensitive diagnostic marker, while MTR may reflect disease burden. A multiparametric qMRI approach may improve diagnosis and monitoring in CIDP.
- 6 April 2026
- Published by Wiley in Muscle & Nerve
- Vol. 73 (6) , 1128-1137
Limb Girdle Muscular Dystrophy Associated With TRIM32 Variants: A National Cohort Study
Introduction/Aims: LGMDR8 is a very rare autosomal recessive limb‐girdle muscular dystrophy caused by variants in the TRIM32 gene. To date, 92 cases have been reported, mainly in the Hutterite population with a founder effect. This study aimed to describe a cohort of European origin and to investigate genotype–phenotype correlations. Methods: We conducted a retrospective, multicenter study of 14 French patients with genetically confirmed LGMDR8. Clinical, histological, electrodiagnostic, imaging, and genetic data were collected and compared with those from previously published cases. Results: Patients showed a slowly progressive disease course, with a mean age at onset of 25.1 years (range 7.5–40.0). The main presenting symptom was proximal lower limb weakness ( n = 13). At last follow‐up, all patients had proximal lower limb weakness, 10/14 had upper limb involvement, and 10/14 had distal lower limb weakness. Six patients lost ambulation (mean disease duration: 27.3 years). No cardiac or respiratory involvement was observed. Mean creatine kinase levels were mildly elevated (4.5× upper limit of normal). Muscle biopsies exhibited dystrophic features. Ragged‐red and COX‐negative fibers were observed in two patients. Muscle magnetic resonance imaging revealed symmetrical involvement predominantly affecting posterior thigh muscles. Fourteen distinct pathogenic variants were identified, including eight new ones. Six variants were located in the C‐terminal domain. LGMDR8 was estimated to account for 0.9% of the LGMD cases in France. No clear genotype–phenotype correlation was found. Discussion: LGMDR8 is very rare in non‐Hutterite patients. Age of onset is highly variable. Variants are distributed across most protein domains and did not predict clinical severity.
- 6 April 2026
- Published by Wiley in Muscle & Nerve
- Vol. 73 (6) , 1128-1137
Limb Girdle Muscular Dystrophy Associated With TRIM32 Variants: A National Cohort Study
Introduction/Aims: LGMDR8 is a very rare autosomal recessive limb‐girdle muscular dystrophy caused by variants in the TRIM32 gene. To date, 92 cases have been reported, mainly in the Hutterite population with a founder effect. This study aimed to describe a cohort of European origin and to investigate genotype–phenotype correlations. Methods: We conducted a retrospective, multicenter study of 14 French patients with genetically confirmed LGMDR8. Clinical, histological, electrodiagnostic, imaging, and genetic data were collected and compared with those from previously published cases. Results: Patients showed a slowly progressive disease course, with a mean age at onset of 25.1 years (range 7.5–40.0). The main presenting symptom was proximal lower limb weakness ( n = 13). At last follow‐up, all patients had proximal lower limb weakness, 10/14 had upper limb involvement, and 10/14 had distal lower limb weakness. Six patients lost ambulation (mean disease duration: 27.3 years). No cardiac or respiratory involvement was observed. Mean creatine kinase levels were mildly elevated (4.5× upper limit of normal). Muscle biopsies exhibited dystrophic features. Ragged‐red and COX‐negative fibers were observed in two patients. Muscle magnetic resonance imaging revealed symmetrical involvement predominantly affecting posterior thigh muscles. Fourteen distinct pathogenic variants were identified, including eight new ones. Six variants were located in the C‐terminal domain. LGMDR8 was estimated to account for 0.9% of the LGMD cases in France. No clear genotype–phenotype correlation was found. Discussion: LGMDR8 is very rare in non‐Hutterite patients. Age of onset is highly variable. Variants are distributed across most protein domains and did not predict clinical severity.